Global Vortioxetine Market Research Report 2023

Vortioxetine Market

Vortioxetine is an atypical antipsychotic and antidepressant indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of serotonin. More specifically, vortioxetine acts via the following biological mechanisms: as a serotonin reuptake inhibitor (SRI) through inhibition of the serotonin transporter, as a partial agonist of the 5-HT1B receptor, an agonist of 5-HT1A, and an antagonist of the 5-HT3, 5-HT1D, and 5-HT7 receptors. 

The global Vortioxetine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Vortioxetine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Vortioxetine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Vortioxetine include Takeda, Lundbeck and CGeneTech, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vortioxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vortioxetine.

The Vortioxetine market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vortioxetine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Vortioxetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Vortioxetine Market Report

Core Chapters

1.1 Product Overview and Scope of Vortioxetine

1.2 Vortioxetine Segment by Type

1.2.1 Global Vortioxetine Market Value Comparison by Type (2023-2029)

1.2.2 5 Mg Tablets

1.2.3 10 Mg Tablet

1.2.4 15 Mg Tablet

1.2.5 20 Mg Tablet

1.3 Vortioxetine Segment by Application

1.3.1 Global Vortioxetine Market Value by Application: (2023-2029)

1.3.2 Depression

1.3.3 Generalized Anxiety Disorder

1.3.4 Attention Deficit Hyperactivity Disorder

1.3.5 Other

1.4 Global Vortioxetine Market Size Estimates and Forecasts

1.4.1 Global Vortioxetine Revenue 2018-2029

1.4.2 Global Vortioxetine Sales 2018-2029

1.4.3 Global Vortioxetine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Vortioxetine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Vortioxetine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Vortioxetine Average Price by Manufacturers (2018-2023)

2.4 Global Vortioxetine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Vortioxetine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Vortioxetine, Product Type & Application

2.7 Vortioxetine Market Competitive Situation and Trends

2.7.1 Vortioxetine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Vortioxetine Players Market Share by Revenue

2.7.3 Global Vortioxetine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Vortioxetine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Vortioxetine Global Vortioxetine Sales by Region: 2018-2029

3.2.1 Global Vortioxetine Sales by Region: 2018-2023

3.2.2 Global Vortioxetine Sales by Region: 2024-2029

3.3 Global Vortioxetine Global Vortioxetine Revenue by Region: 2018-2029

3.3.1 Global Vortioxetine Revenue by Region: 2018-2023

3.3.2 Global Vortioxetine Revenue by Region: 2024-2029

3.4 North America Vortioxetine Market Facts & Figures by Country

3.4.1 North America Vortioxetine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Vortioxetine Sales by Country (2018-2029)

3.4.3 North America Vortioxetine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Vortioxetine Market Facts & Figures by Country

3.5.1 Europe Vortioxetine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Vortioxetine Sales by Country (2018-2029)

3.5.3 Europe Vortioxetine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Vortioxetine Market Facts & Figures by Country

3.6.1 Asia Pacific Vortioxetine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Vortioxetine Sales by Country (2018-2029)

3.6.3 Asia Pacific Vortioxetine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Vortioxetine Market Facts & Figures by Country

3.7.1 Latin America Vortioxetine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Vortioxetine Sales by Country (2018-2029)

3.7.3 Latin America Vortioxetine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Vortioxetine Market Facts & Figures by Country

3.8.1 Middle East and Africa Vortioxetine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Vortioxetine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Vortioxetine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Vortioxetine Sales by Type (2018-2029)

4.1.1 Global Vortioxetine Sales by Type (2018-2023)

4.1.2 Global Vortioxetine Sales by Type (2024-2029)

4.1.3 Global Vortioxetine Sales Market Share by Type (2018-2029)

4.2 Global Vortioxetine Revenue by Type (2018-2029)

4.2.1 Global Vortioxetine Revenue by Type (2018-2023)

4.2.2 Global Vortioxetine Revenue by Type (2024-2029)

4.2.3 Global Vortioxetine Revenue Market Share by Type (2018-2029)

4.3 Global Vortioxetine Price by Type (2018-2029)

5.1 Global Vortioxetine Sales by Application (2018-2029)

5.1.1 Global Vortioxetine Sales by Application (2018-2023)

5.1.2 Global Vortioxetine Sales by Application (2024-2029)

5.1.3 Global Vortioxetine Sales Market Share by Application (2018-2029)

5.2 Global Vortioxetine Revenue by Application (2018-2029)

5.2.1 Global Vortioxetine Revenue by Application (2018-2023)

5.2.2 Global Vortioxetine Revenue by Application (2024-2029)

5.2.3 Global Vortioxetine Revenue Market Share by Application (2018-2029)

5.3 Global Vortioxetine Price by Application (2018-2029)

6.1 Takeda

6.1.1 Takeda Corporation Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Vortioxetine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Takeda Vortioxetine Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 Lundbeck

6.2.1 Lundbeck Corporation Information

6.2.2 Lundbeck Description and Business Overview

6.2.3 Lundbeck Vortioxetine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Lundbeck Vortioxetine Product Portfolio

6.2.5 Lundbeck Recent Developments/Updates

6.3 CGeneTech

6.3.1 CGeneTech Corporation Information

6.3.2 CGeneTech Description and Business Overview

6.3.3 CGeneTech Vortioxetine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 CGeneTech Vortioxetine Product Portfolio

6.3.5 CGeneTech Recent Developments/Updates

7.1 Vortioxetine Industry Chain Analysis

7.2 Vortioxetine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Vortioxetine Production Mode & Process

7.4 Vortioxetine Sales and Marketing

7.4.1 Vortioxetine Sales Channels

7.4.2 Vortioxetine Distributors

7.5 Vortioxetine Customers

8.1 Vortioxetine Industry Trends

8.2 Vortioxetine Market Drivers

8.3 Vortioxetine Market Challenges

8.4 Vortioxetine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Vortioxetine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Vortioxetine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Vortioxetine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Vortioxetine Sales (M Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Vortioxetine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Vortioxetine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Vortioxetine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Vortioxetine Average Price (US$/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Vortioxetine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Vortioxetine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Vortioxetine, Product Type & Application

    Table 12. Global Key Manufacturers of Vortioxetine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Vortioxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vortioxetine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Vortioxetine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Vortioxetine Sales by Region (2018-2023) & (M Pcs)

    Table 18. Global Vortioxetine Sales Market Share by Region (2018-2023)

    Table 19. Global Vortioxetine Sales by Region (2024-2029) & (M Pcs)

    Table 20. Global Vortioxetine Sales Market Share by Region (2024-2029)

    Table 21. Global Vortioxetine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Vortioxetine Revenue Market Share by Region (2018-2023)

    Table 23. Global Vortioxetine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Vortioxetine Revenue Market Share by Region (2024-2029)

    Table 25. North America Vortioxetine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Vortioxetine Sales by Country (2018-2023) & (M Pcs)

    Table 27. North America Vortioxetine Sales by Country (2024-2029) & (M Pcs)

    Table 28. North America Vortioxetine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Vortioxetine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Vortioxetine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Vortioxetine Sales by Country (2018-2023) & (M Pcs)

    Table 32. Europe Vortioxetine Sales by Country (2024-2029) & (M Pcs)

    Table 33. Europe Vortioxetine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Vortioxetine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Vortioxetine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Vortioxetine Sales by Region (2018-2023) & (M Pcs)

    Table 37. Asia Pacific Vortioxetine Sales by Region (2024-2029) & (M Pcs)

    Table 38. Asia Pacific Vortioxetine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Vortioxetine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Vortioxetine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Vortioxetine Sales by Country (2018-2023) & (M Pcs)

    Table 42. Latin America Vortioxetine Sales by Country (2024-2029) & (M Pcs)

    Table 43. Latin America Vortioxetine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Vortioxetine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Vortioxetine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Vortioxetine Sales by Country (2018-2023) & (M Pcs)

    Table 47. Middle East & Africa Vortioxetine Sales by Country (2024-2029) & (M Pcs)

    Table 48. Middle East & Africa Vortioxetine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Vortioxetine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Vortioxetine Sales (M Pcs) by Type (2018-2023)

    Table 51. Global Vortioxetine Sales (M Pcs) by Type (2024-2029)

    Table 52. Global Vortioxetine Sales Market Share by Type (2018-2023)

    Table 53. Global Vortioxetine Sales Market Share by Type (2024-2029)

    Table 54. Global Vortioxetine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Vortioxetine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Vortioxetine Revenue Market Share by Type (2018-2023)

    Table 57. Global Vortioxetine Revenue Market Share by Type (2024-2029)

    Table 58. Global Vortioxetine Price (US$/Pcs) by Type (2018-2023)

    Table 59. Global Vortioxetine Price (US$/Pcs) by Type (2024-2029)

    Table 60. Global Vortioxetine Sales (M Pcs) by Application (2018-2023)

    Table 61. Global Vortioxetine Sales (M Pcs) by Application (2024-2029)

    Table 62. Global Vortioxetine Sales Market Share by Application (2018-2023)

    Table 63. Global Vortioxetine Sales Market Share by Application (2024-2029)

    Table 64. Global Vortioxetine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Vortioxetine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Vortioxetine Revenue Market Share by Application (2018-2023)

    Table 67. Global Vortioxetine Revenue Market Share by Application (2024-2029)

    Table 68. Global Vortioxetine Price (US$/Pcs) by Application (2018-2023)

    Table 69. Global Vortioxetine Price (US$/Pcs) by Application (2024-2029)

    Table 70. Takeda Corporation Information

    Table 71. Takeda Description and Business Overview

    Table 72. Takeda Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 73. Takeda Vortioxetine Product

    Table 74. Takeda Recent Developments/Updates

    Table 75. Lundbeck Corporation Information

    Table 76. Lundbeck Description and Business Overview

    Table 77. Lundbeck Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 78. Lundbeck Vortioxetine Product

    Table 79. Lundbeck Recent Developments/Updates

    Table 80. CGeneTech Corporation Information

    Table 81. CGeneTech Description and Business Overview

    Table 82. CGeneTech Vortioxetine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2023)

    Table 83. CGeneTech Vortioxetine Product

    Table 84. CGeneTech Recent Developments/Updates

    Table 85. Key Raw Materials Lists

    Table 86. Raw Materials Key Suppliers Lists

    Table 87. Vortioxetine Distributors List

    Table 88. Vortioxetine Customers List

    Table 89. Vortioxetine Market Trends

    Table 90. Vortioxetine Market Drivers

    Table 91. Vortioxetine Market Challenges

    Table 92. Vortioxetine Market Restraints

    Table 93. Research Programs/Design for This Report

    Table 94. Key Data Information from Secondary Sources

    Table 95. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Vortioxetine

    Figure 2. Global Vortioxetine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Vortioxetine Market Share by Type in 2022 & 2029

    Figure 4. 5 Mg Tablets Product Picture

    Figure 5. 10 Mg Tablet Product Picture

    Figure 6. 15 Mg Tablet Product Picture

    Figure 7. 20 Mg Tablet Product Picture

    Figure 8. Global Vortioxetine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Vortioxetine Market Share by Application in 2022 & 2029

    Figure 10. Depression

    Figure 11. Generalized Anxiety Disorder

    Figure 12. Attention Deficit Hyperactivity Disorder

    Figure 13. Other

    Figure 14. Global Vortioxetine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Vortioxetine Market Size (2018-2029) & (US$ Million)

    Figure 16. Global Vortioxetine Sales (2018-2029) & (M Pcs)

    Figure 17. Global Vortioxetine Average Price (US$/Pcs) & (2018-2029)

    Figure 18. Vortioxetine Report Years Considered

    Figure 19. Vortioxetine Sales Share by Manufacturers in 2022

    Figure 20. Global Vortioxetine Revenue Share by Manufacturers in 2022

    Figure 21. The Global 5 and 10 Largest Vortioxetine Players: Market Share by Revenue in 2022

    Figure 22. Vortioxetine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 23. Global Vortioxetine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 24. North America Vortioxetine Sales Market Share by Country (2018-2029)

    Figure 25. North America Vortioxetine Revenue Market Share by Country (2018-2029)

    Figure 26. U.S. Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Canada Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Europe Vortioxetine Sales Market Share by Country (2018-2029)

    Figure 29. Europe Vortioxetine Revenue Market Share by Country (2018-2029)

    Figure 30. Germany Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. France Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. U.K. Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Italy Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Russia Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Asia Pacific Vortioxetine Sales Market Share by Region (2018-2029)

    Figure 36. Asia Pacific Vortioxetine Revenue Market Share by Region (2018-2029)

    Figure 37. China Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Japan Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. South Korea Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. India Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Australia Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Taiwan Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Indonesia Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Thailand Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Malaysia Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Philippines Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Latin America Vortioxetine Sales Market Share by Country (2018-2029)

    Figure 48. Latin America Vortioxetine Revenue Market Share by Country (2018-2029)

    Figure 49. Mexico Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Brazil Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Argentina Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Vortioxetine Sales Market Share by Country (2018-2029)

    Figure 53. Middle East & Africa Vortioxetine Revenue Market Share by Country (2018-2029)

    Figure 54. Turkey Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Saudi Arabia Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. UAE Vortioxetine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Global Sales Market Share of Vortioxetine by Type (2018-2029)

    Figure 58. Global Revenue Market Share of Vortioxetine by Type (2018-2029)

    Figure 59. Global Vortioxetine Price (US$/Pcs) by Type (2018-2029)

    Figure 60. Global Sales Market Share of Vortioxetine by Application (2018-2029)

    Figure 61. Global Revenue Market Share of Vortioxetine by Application (2018-2029)

    Figure 62. Global Vortioxetine Price (US$/Pcs) by Application (2018-2029)

    Figure 63. Vortioxetine Value Chain

    Figure 64. Vortioxetine Production Process

    Figure 65. Channels of Distribution (Direct Vs Distribution)

    Figure 66. Distributors Profiles

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed